Treatment-refractory active systemic lupus erythematosus research hub

A study evaluating the safety, tolerability, and efficacy of GLPG5101 in adults with treatment-refractory active systemic lupus erythematosus

This study is testing a new medicine called GLPG5101 for adults with a type of lupus that hasn't responded to other treatments. It's looking at how safe the medicine is, if people can tolerate it well, and if it helps relieve lupus symptoms.